Cooperative Agreement NH23IP922664

This $1,100,000 Cooperative Agreement, awarded by the Centers for Disease Control and Prevention (CDC) under the Global Tuberculosis: Developing, Evaluating, Implementing Evidence-based and Innovative Approaches to Find, Cure, and Prevent Tuberculosis Globally (CFDA 93.494) program, will support collaboration between the International Union Against Tuberculosis and Lung Disease (Uitmr) and the CDC to transform evidence into practice and end the tuberculosis (TB) epidemic in resource-limited...

This Cooperative Agreement, awarded by the Uniformed Services University of the Health Sciences (CFDA 12.750 - Uniformed Services University Medical Research Projects), provides $2,687,739.00 in funding for "GLOBAL HEALTH ENGAGEMENT (GHE) RESEARCH ACTIVITIES" to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The award period runs from August 12, 2024 to March 31, 2029. The key products and services to be delivered under this Cooperative Agreement include...

This $287,878,180 Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program is intended to scale up and improve the management of drug-resistant tuberculosis (DR-TB) in USAID-supported countries. The award aims to expand access to high-quality DR-TB treatment services and provide specialized technical assistance to enhance DR-TB program quality in TB priority and Global Fund technical...

The Centers for Disease Control and Prevention (CDC) awarded a $3,710,204 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to Humana People To People Congo (HPP-Congo), a non-profit organization based in the Democratic Republic of the Congo (DRC). The award, titled "TOTAL CONTROL OF THE EPIDEMIC TCE KINSHASA", will fund a 5-year project (2024-2029) to strengthen HIV/TB prevention, detection, and treatment services in Kinshasa Province, DRC. Key objectives include...

The U.S. Centers for Disease Control and Prevention (CDC) has awarded a $10,151,871 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to the University of California, San Francisco (UCSF) to lead the Alliance for Country-Led Control of the HIV Epidemic by Leveraging Efficient Resource Allocation to Achieve Equity (ACCELERATE) consortium. This 4-year award, effective September 30, 2024, aims to promote sustainable, data-driven, and equitable HIV/AIDS programs in Kenya, Uganda,...

This $7,410,542 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) supports the "INGANJI RWANDA: EVIDENCE-BASED HIV PREVENTION AND CARE FOR KEY AND PRIORITY POPULATIONS" project led by the Center for Family Health Research (CFHR) in Rwanda. The project aims to optimize access to and use of evidence-based HIV prevention, testing, and treatment interventions among key and priority populations in Rwanda,...

This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Sexually Transmitted Diseases (STD) Prevention and Control Grants program (CFDA 93.977) provides $8,595,118.00 to the World Health Organization (WHO) from September 30, 2024 to September 29, 2029 to strengthen public health capacity and guidelines for implementing HIV programs. The award supports a range of activities including disease surveillance, testing and treatment services,...

This $6,480,574 Cooperative Agreement awarded by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program aims to control and prevent the spread of tuberculosis in the Visayas and Mindanao regions of the Philippines. The award recipient, Tropical Disease Foundation Inc. (TDF), a foreign-owned non-profit organization based in the Philippines, will deliver products and services focused on tuberculosis research, prevention,...

This Cooperative Agreement award from the Defense Health Agency (DHA) under the Department of Defense HIV/AIDS Prevention Program (CFDA 12.350) provides $712,771 in funding to Labyrinth Global Health, Inc. to support the "REPUBLIC OF SIERRA LEONE ARMED FORCES: PARTNERSHIP FOR SUSTAINABLE HIV EPIDEMIC CONTROL" project. The purpose of this award is to provide additional funding of $41,771 to the existing project, which aims to establish and implement HIV/AIDS prevention, care, and...

This Cooperative Agreement, awarded by the U.S. Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067), provides $11,097,080 to Global Health Systems Solutions (GHSS) to build laboratory capacity and improve quality of HIV testing services in the Democratic Republic of the Congo (DRC). The key objectives are to: 1) scale up quality assurance and improvement for HIV rapid testing and TB testing; 2) increase coverage and timeliness of viral load, early...